3/2
01:14 pm
dmac
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
Low
Report
Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight [Yahoo! Finance]
2/24
09:49 am
dmac
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/24
09:23 am
dmac
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
Neutral
Report
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
1/16
05:00 pm
dmac
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/5
09:10 am
dmac
DiaMedica Therapeutics (NASDAQ:DMAC) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Medium
Report
DiaMedica Therapeutics (NASDAQ:DMAC) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
12/18
09:20 am
dmac
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA [Yahoo! Finance]
Low
Report
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA [Yahoo! Finance]
12/18
08:45 am
dmac
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
Low
Report
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA